Emerging roles of SARS-CoV-2 Spike-ACE2 in immune evasion and pathogenesis
Trends in Immunology · 2023
DOI: 10.1016/j.it.2023.04.001 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Immunology, 2023. Verfasst von Cosima T Baldari und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, University of Siena, Siena, Italy. Electronic address: cosima.baldari@unisi.it. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Research Council.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Life Sciences, University of Siena, Siena, Italy. Electronic address: cosima.baldari@unisi.it.
- Department of Life Sciences, University of Siena, Siena, Italy.
- Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy.
- Independent Consultant, Siena, Italy.
- Fondazione Biotecnopolo di Siena, Siena, Italy; Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, Italy. Electronic address: rino.rappuoli@biotecnopolo.it.
Förderung
- European Research Council
Zitieren
APA
Baldari, C. T., Onnis, A., Andreano, E., Del Giudice, G., & Rappuoli, R. (2023). Emerging roles of SARS-CoV-2 Spike-ACE2 in immune evasion and pathogenesis. Trends in Immunology. https://doi.org/10.1016/j.it.2023.04.001
Vancouver
Baldari CT, Onnis A, Andreano E, Del Giudice G, Rappuoli R. Emerging roles of SARS-CoV-2 Spike-ACE2 in immune evasion and pathogenesis. Trends in Immunology. 2023. doi:10.1016/j.it.2023.04.001
BibTeX
@article{Baldari2023,
author = {Baldari, Cosima T and Onnis, Anna and Andreano, Emanuele and Del Giudice, Giuseppe and Rappuoli, Rino},
title = {Emerging roles of SARS-CoV-2 Spike-ACE2 in immune evasion and pathogenesis},
journal = {Trends in Immunology},
year = {2023},
doi = {10.1016/j.it.2023.04.001}
}
EUVIMED